Market Overview

JANA Partners Addresses Charles River's Latest Defense of Proposed WuXi Acquisition (CRL, WX)


JANA Partners LLC today sent Charles River Laboratories International, Inc. (NYSE: CRL) a detailed critique of Charles River's revised investor presentation released earlier this week, in which Charles River once again seeks to persuade shareholders of the merits of its proposed acquisition of WuXi PharmaTech (Cayman) Inc. (NYSE: WX).

Posted-In: News Management M&A Global Pre-Market Outlook Intraday Update Press Releases


Related Articles (CRL + WX)

View Comments and Join the Discussion!

Partner Center